MicroRNA hsa-miR-665 prevents cardiomyocyte hypertrophy and preserves normal cardiac function after pressure overload

被引：0
|
作者：
Braga, L. [1 ]
Dal Ferro, M. [1 ,2 ]
Mano, M. [1 ]
Eulalio, A. [1 ]
Moimas, S. [1 ]
Zentilin, L. [1 ]
Zacchigna, S. [1 ]
Giacca, M. [1 ]
机构：
[1] ICGEB, Mol Med Lab, Trieste, Italy
[2] Azienda Sanit Univ Integrata Trieste, Dept Cardiol, Trieste, Italy
来源：
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2017年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2
引用
收藏
页码：1 / 2
页数：2
相关论文
共 30 条
  • [1] hsa-miR-665 Prevents Cardiomyocyte Hypertrophy and Preserve Normal Cardiac Function After Pressure Overload
    Braga, Luca
    Dal Ferro, Matteo
    Mano, Miguel
    Eulalio, Ana
    Moimas, Silvia
    Zentilin, Lorena
    Zacchigna, Serena
    Giacca, Mauro
    MOLECULAR THERAPY, 2017, 25 (05) : 27 - 27
  • [2] Administration of miR-665 modulates cardiomiocyte mechanotransduction and prevents pathological cardiac remodelling after pressure overload
    Braga, L.
    Dal Ferro, M.
    Mano, M.
    Eulalio, A.
    Ali, H.
    Cannata, A.
    Torrini, C.
    Zentilin, L.
    Zacchigna, S.
    Giacca, M.
    CARDIOVASCULAR RESEARCH, 2018, 114 : S60 - S60
  • [3] Exercise Training Prevents Cardiomyocyte Apoptosis And Preserves Myocardial Integrity In Acute Cardiac Pressure Overload
    Moreira-Goncalves, Daniel
    Henriques-Coelho, Tiago
    Fonseca, Helder
    Goncalves, Nadia
    Duarte, Jose Alberto
    Leite-Moreira, Adelino
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2010, 42 (05): : 545 - 545
  • [4] Sacubitril/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload
    Norden, Einar Sjaastad
    Bendiksen, Bard Andre
    Andresen, Henriette
    Bergo, Kaja Knudsen
    Espe, Emil Knut
    Hasic, Almira
    Hauge-Iversen, Ida Marie
    Veras, Ioanni
    Hussain, Rizwan I.
    Sjaastad, Ivar
    Christensen, Geir
    Cataliotti, Alessandro
    ESC HEART FAILURE, 2021, 8 (02): : 918 - 927
  • [5] Cardiomyocyte TRPV4 deletion preserves cardiac function following pressure overload-induced pathological hypertrophy independent of cardiac fibrosis
    Adapala, Ravi
    Ohanyan, Vahagn
    Paruchuri, Sailaja
    Chilian, William
    Thodeti, Charles
    FASEB JOURNAL, 2021, 35
  • [6] Therapeutic Cardiac-Targeted Delivery of Mir-1 Reverses Hypertrophy and Preserves Cardiac Function in a Pressure Overload Animal Model
    Karakikes, Ioannis
    Chaanine, Antoine
    Kim, Jaewon
    Lebeche, Djamel
    Hajjar, Roger J.
    CIRCULATION, 2010, 122 (21)
  • [7] Cardiac mTOR complex 2 preserves ventricular function in pressure-overload hypertrophy
    Shende, Pankaj
    Xu, Lifen
    Morandi, Christian
    Pentassuglia, Laura
    Heim, Philippe
    Lebboukh, Sonia
    Berthonneche, Corinne
    Pedrazzini, Thierry
    Kaufmann, Beat A.
    Hall, Michael N.
    Rueegg, Markus A.
    Brink, Marijke
    CARDIOVASCULAR RESEARCH, 2016, 109 (01) : 103 - 114
  • [8] MiR-125a-5p Regulates Cardiomyocyte Function and Prevents Pressure-Overload Induced Cardiac Dysfunction
    Verjans, Robin
    Vodret, Simone
    Dal Ferro, Matteo
    Braga, Luca
    Rech, Monika
    Hermans-Beijnsberger, Steffie
    Spatjens, Roel
    van Bilsen, Marc
    Giacca, Mauro
    Schroen, Blanche
    MOLECULAR THERAPY, 2019, 27 (04) : 51 - 51
  • [9] Caspase Inhibition Prevents Hypertrophy and Improves Cardiac Function with Chronic Pressure Overload
    Park, Misun
    Lee, Jung Ah
    Gao, Shumin
    Yoon, SeongHun
    Xie, Lai-Hua
    Charles, Ludny
    Leibovich, Samuel J.
    Kitsis, Richard N.
    Vatner, Stephen F.
    Vatner, Dorothy E.
    CIRCULATION, 2011, 124 (21)
  • [10] Maintaining Cardiac Fatty Acid Oxidation in Pressure-Overload Hypertrophy Preserves Function and Energetics
    Kolwicz, Stephen C., Jr.
    Olson, David P.
    Marney, Luke
    Garcia-Menendez, Lorena
    Ngoy, Soeun
    Synovec, Robert E.
    Liao, Ronglih
    Tian, Rong
    CIRCULATION, 2011, 124 (21)
123